These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
12. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
13. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
14. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
15. Sales from licensed and acquired products to increase by 2013. Goodman M Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704 [No Abstract] [Full Text] [Related]
16. Patent watch: Drug patenting in India: looking back and looking forward. Sampat BN; Shadlen KC Nat Rev Drug Discov; 2015 Aug; 14(8):519-20. PubMed ID: 26184492 [No Abstract] [Full Text] [Related]
17. Patent highlights October-November 2017. Mucke HA Pharm Pat Anal; 2018 Mar; 7(2):73-81. PubMed ID: 29417883 [TBL] [Abstract][Full Text] [Related]
18. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
19. The use of generic or patent medicines in the Netherlands. Gebhardt DO J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361 [No Abstract] [Full Text] [Related]
20. Five years on...and four challenges for the pharmaceutical industry. Nat Rev Drug Discov; 2007 Jan; 6(1):3. PubMed ID: 17269156 [No Abstract] [Full Text] [Related] [Next] [New Search]